Skip to content
Preprint · OA via OpenAlex

Biomarkers of Kidney Injury and Klotho in Patients with Atherosclerotic Renovascular Disease

Moo Yong Park, Sandra M. Herrmann, Ahmed Saad, Alfonso Eirin, Hui Jun Tang, Stephen C. Textor, Amir Lerman

Clinical Journal of the American Society of Nephrology · 2014 · ▲ 41 citations

Abstract

BACKGROUND AND OBJECTIVES: Occlusive renovascular disease and hypertension may progress to CKD. Circulating levels of several biomarkers, including fibroblast growth factor (FGF)-23, Klotho, and soluble urokinase plasminogen activator receptor (suPAR), are altered in patients with CKD, but their role in essential hypertension (EH) and renovascular hypertension (RVH) remains unclear. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Levels of FGF-23, Klotho, suPAR, plasminogen activator inhibitor (PAI)-1, tissue factor, and tissue factor pathway inhibitor (TFI) were measured in the inferior vena cava and renal vein of hypertensive patients with atherosclerotic renal artery stenosis (n=12) or age-matched participants with EH (n=12) and relatively preserved renal function. Single-kidney blood flow was measured to calculate renal release of markers. For control, peripheral vein levels were measured in healthy volunteers (HVs; n=12). RESULTS: FGF-23 levels did not differ among the groups, whereas Klotho levels were lower in participants with RVH and EH than in HVs, and suPAR levels were elevated in patients with RVH compared with HVs and patients with EH (6.1±1.5 versus 4.4±1.9 and 3.2±1.2 ng/ml, P<0.05). PAI-1 levels were higher in patients with RVH than in patients with EH, but tissue factor and TFI levels were not statistically significantly different. After adjustment for GFR, Klotho levels remained decreased in both RVH and EH, and suPAR and PAI-1 levels remained elevated in RVH. eGFR correlated inversely with systemic and renal vein suPAR levels, and directly with systemic Klotho levels. CONCLUSIONS: Klotho levels are low in hypertensive patients, whereas suPAR and PAI-1 levels are specifically elevated in RVH, correlating with GFR. Klotho, PAI-1, and suPAR may be markers of kidney injury in hypertensive patients.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.2215/cjn.07290714
Canonical
link ↗
Fetched
2026-10-26 MST

Cite this

APA
Park, M.Y., Herrmann, S.M., Saad, A., Eirin, A., Tang, H.J., Textor, S.C., &amp; Lerman, A. (2014). Biomarkers of Kidney Injury and Klotho in Patients with Atherosclerotic Renovascular Disease. <em>Clinical Journal of the American Society of Nephrology</em>. https://doi.org/10.2215/cjn.07290714
Vancouver
Park MY, Herrmann SM, Saad A, Eirin A, Tang HJ, Textor SC, et al. Biomarkers of Kidney Injury and Klotho in Patients with Atherosclerotic Renovascular Disease. Clinical Journal of the American Society of Nephrology. 2014. doi:10.2215/cjn.07290714.
BibTeX
@unpublished{moo2014Biomar, title = {Biomarkers of Kidney Injury and Klotho in Patients with Atherosclerotic Renovascular Disease}, author = {Moo Yong Park and Sandra M. Herrmann and Ahmed Saad and Alfonso Eirin and Hui Jun Tang and Stephen C. Textor and Amir Lerman}, journal = {Clinical Journal of the American Society of Nephrology}, year = {2014}, doi = {10.2215/cjn.07290714}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings